Yong-Seok Heo

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Structural Basis

Top Venues

Nature communications

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Pritam Giri, Seonga Lim, Taresh P Khobragade, Amol D Pagar, Mahesh D Patil, Sharad Sarak, Hyunwoo Jeon, Sangwoo Joo, Younghwan Goh, Seohee Jung, Yu-Jeong Jang, Seung Beom Choi, Ye Chan Kim, Taek Jin Kang, Yong-Seok Heo, Hyungdon Yun
Biocatalysis enables the scalable conversion of biobased furans into various furfurylamines. Nature communications 15 (1) (2024)
Pritam Giri, Seonga Lim, Taresh P Khobragade, Amol D Pagar, Mahesh D Patil, Sharad Sarak, Hyunwoo Jeon, Sangwoo Joo, Younghwan Goh, Seohee Jung, Yu-Jeong Jang, Seung Beom Choi, Ye Chan Kim, Taek Jin Kang, Yong-Seok Heo, Hyungdon Yun
Biocatalysis enables the scalable conversion of biobased furans into various furfurylamines. Nature communications 15 (1) (2024)
Pritam Giri, Seonga Lim, Taresh P Khobragade, Amol D Pagar, Mahesh D Patil, Sharad Sarak, Hyunwoo Jeon, Sangwoo Joo, Younghwan Goh, Seohee Jung, Yu-Jeong Jang, Seung Beom Choi, Ye Chan Kim, Taek Jin Kang, Yong-Seok Heo, Hyungdon Yun
Biocatalysis enables the scalable conversion of biobased furans into various furfurylamines. Nature communications 15 (1) (2024)
Yong-Seok Heo
Recent Advances in Antibody Therapeutics. International journal of molecular sciences 23 (7) (2022)
Tae-Jun Jeong, Hyun Tae Lee, Nahyeon Gu, Yu-Jeong Jang, Seung-Beom Choi, Ui-Beom Park, Sang-Hyung Lee, Yong-Seok Heo
The High-Resolution Structure Reveals Remarkable Similarity in PD-1 Binding of Cemiplimab and Dostarlimab, the FDA-Approved Antibodies for Cancer Immunotherapy. Biomedicines 10 (12) (2022)
Tae-Jun Jeong, Hyun Tae Lee, Nahyeon Gu, Yu-Jeong Jang, Seung-Beom Choi, Ui-Beom Park, Sang-Hyung Lee, Yong-Seok Heo
The High-Resolution Structure Reveals Remarkable Similarity in PD-1 Binding of Cemiplimab and Dostarlimab, the FDA-Approved Antibodies for Cancer Immunotherapy. Biomedicines 10 (12) (2022)
Hyun Tae Lee, Sang Hyung Lee, Yong-Seok Heo
Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology. Molecules (Basel, Switzerland) 24 (6) (2019)
Heejin Lim, Sang Hyung Lee, Hyun Tae Lee, Jee Un Lee, Ji Young Son, Woori Shin, Yong-Seok Heo
Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis. International journal of molecular sciences 19 (3) (2018)